We serve (S)-N-(tert-Butyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide CAS:149182-72-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (S)-N-(tert-Butyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
CAS.NO: 149182-72-9
Synonyms:
(3S)-N-(TERT-BUTYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE
(S)-(−)-N-tert-Butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
Molecular Formula: C14H20N2O
Molecular Weight: 232.32100
Physical and Chemical Properties:
Density: 1.046 g/cm3
Boiling point: 426.8ºC at 760 mmHg
Melting point: 98-99 °C(lit.)
Flash point:166.9±25.8 °C
Refractive index: 1.529
Specification:
Appearance: Off-white crystalline powder
Purity:≥99%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Storage conditions: 2-8ºC.Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Nelfinavir mesylate CAS: 159989-65-8
Contact us for information like (S)-N-(tert-Butyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-(−)-N-tert-Butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-(−)-N-tert-Butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide Use and application,(3S)-N-(TERT-BUTYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE technical grade,usp/ep/jp grade.
Related News: As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made “due to the continued drop in demand for travel to China and the US Department of State’s decision to raise its China travel advisory to a Level 4.”(R)-2-Methyl-CBS-oxazaborolidine manufacturer From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.Propyl bromoacetate supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.5-Bromo-2-chlorobenzotrifluoride vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased.
